A new trading day began on Monday, with Mira Pharmaceuticals Inc (NASDAQ: MIRA) stock price down -4.55% from the previous day of trading, before settling in for the closing price of $1.10. MIRA’s price has ranged from $0.51 to $6.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 21.88%. With a float of $9.96 million, this company’s outstanding shares have now reached $14.78 million.
Let’s look at the performance matrix of the company that is accounted for 3 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mira Pharmaceuticals Inc (MIRA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Mira Pharmaceuticals Inc is 32.64%, while institutional ownership is 4.75%. The most recent insider transaction that took place on Sep 04 ’24, was worth 18,000. Before that another transaction happened on Aug 28 ’24, when Company’s 10% Owner sold 200,000 for $1.96, making the entire transaction worth $392,000. This insider now owns 2,540,270 shares in total.
Mira Pharmaceuticals Inc (MIRA) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.26 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.88% per share during the next fiscal year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Here are Mira Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Mira Pharmaceuticals Inc (NASDAQ: MIRA) saw its 5-day average volume 0.81 million, a negative change from its year-to-date volume of 2.08 million. As of the previous 9 days, the stock’s Stochastic %D was 40.16%. Additionally, its Average True Range was 0.11.
During the past 100 days, Mira Pharmaceuticals Inc’s (MIRA) raw stochastic average was set at 12.00%, which indicates a significant increase from 12.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.36% in the past 14 days, which was lower than the 349.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4376, while its 200-day Moving Average is $1.1660. Nevertheless, the first resistance level for the watch stands at $1.1533 in the near term. At $1.2567, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3133. If the price goes on to break the first support level at $0.9933, it is likely to go to the next support level at $0.9367. Assuming the price breaks the second support level, the third support level stands at $0.8333.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Key Stats
With a market capitalization of 15.52 million, the company has a total of 14,781K Shares Outstanding. Currently, annual sales are 0 K while annual income is -11,980 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,690 K.
